Kinome Profiling Technologies
Endogenous Kinase Profiling in
Cells, Tissues and Clinical Samples
Pepscope develops protein kinase profiling technologies, but not as you know it. We entirely focus on ultra-sensitive assays to measure multiple endogenous kinase activities inside cells, tissues and clinical samples.
In our QuantaKinome™ technology, we apply a patented targeted mass spectrometry method, designed to provide sensitive, quantitative and robust detection of endogenous kinase activities in precious cell- and tissue samples.
Pepscope aims to make protein kinase inhibitors better therapeutics by providing unique insights into their functioning. We want to accelerate drug development by giving pharma and academic researchers crucial information about in vivo effects of kinase inhibitors on the kinome, leading to more efficacious therapies for targeted patient groups. We believe that our kinome profiling solutions will become a gold standard in signal transduction, kinase research, and drug development.
Peptide from the Ancient Greek word πεπτός, peptós "digested"; derived from πέσσειν, péssein "to digest". Scope from the Ancient Greek word σκοπεῖν, skopeîn, "to look" or "see".